Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade.

Fan M, Goodwin M, Vu T, Brantley-Finley C, Gaarde WA, Chambers TC.

J Biol Chem. 2000 Sep 29;275(39):29980-5.

2.
6.

Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells.

Mc Gee MM, Campiani G, Ramunno A, Nacci V, Lawler M, Williams DC, Zisterer DM.

J Biol Chem. 2002 May 24;277(21):18383-9. Epub 2002 Feb 20.

9.
10.
11.

Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.

Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV.

Oncogene. 2004 Jul 22;23(33):5594-606.

PMID:
15184882
12.
15.
16.

The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells.

Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H.

Carcinogenesis. 2004 May;25(5):647-59. Epub 2003 Dec 19.

PMID:
14688022
17.

The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide.

Brantley-Finley C, Lyle CS, Du L, Goodwin ME, Hall T, Szwedo D, Kaushal GP, Chambers TC.

Biochem Pharmacol. 2003 Aug 1;66(3):459-69.

PMID:
12907245
18.

Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells.

Kolonics A, Apáti A, Jánossy J, Brózik A, Gáti R, Schaefer A, Magócsi M.

Cell Signal. 2001 Oct;13(10):743-54.

PMID:
11602185
19.

Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways.

Yu C, Subler M, Rahmani M, Reese E, Krystal G, Conrad D, Dent P, Grant S.

Cancer Biol Ther. 2003 Sep-Oct;2(5):544-51.

PMID:
14614324

Supplemental Content

Support Center